The “Vaccines 2024 Best Paper Award” is for research and review articles published in Vaccines from 1 January 2022 to 31 December 2022. Two reviews and two research articles will receive an award each. The papers will be selected after a thorough evaluation by the journal Award Committee led by the Editor-in-Chief, Prof. Dr. Ralph A. Tripp.
Eligibility for the Award:
– Papers published in Vaccines from 1 January 2022 to 31 December 2022;
– Open to all career levels;
– Both regular and Special Issue submissions will be considered.
Selection Criteria:
The papers will be selected by the journal Award Committee according to the following criteria:
– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.
The Prize for Each Winner:
– Two review awards: CHF 400 and a chance to publish a paper free of charge in Vaccines in 2024 after peer review;
– Two research article awards: CHF 500 and a chance to publish a paper free of charge in Vaccines in 2024 after peer review;
– Each winner will also receive an electronic certificate.
The winners will be announced on the journal website in March 2024.
